1
89Zr-atezolizumab PET Scan and Lobular Breast Cancer
Condition(s):Lobular Metastatic Breast CancerLast Updated:July 1, 2022Terminated
Hide Studies Not Open or Pending
Condition(s):Lobular Metastatic Breast CancerLast Updated:July 1, 2022Terminated
Condition(s):Diffuse Large B-Cell Lymphoma, Not Otherwise SpecifiedLast Updated:May 15, 2023Withdrawn
Condition(s):Large B-cell LymphomaLast Updated:November 29, 2023Recruiting
Condition(s):Rectal Cancer Stage; Oesophageal CancerLast Updated:March 15, 2024Recruiting
Condition(s):Metastatic Triple-Negative Breast CarcinomaLast Updated:October 4, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.